Business Context and Reporting Period
This Form 8-K Current Report was filed by AgeX Therapeutics, Inc. (trading symbol: AGE) on January 4, 2021, covering the event date of January 1, 2021. The registrant is an emerging growth company incorporated in Delaware. The filing reports a change in the company's principal executive offices.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on a corporate administrative event rather than financial performance.
Material Changes
Effective January 1, 2021, AgeX Therapeutics, Inc. relocated its principal offices and laboratory facility. The move occurred following the expiration of the lease for its former facility on December 31, 2020.
- New Location: 1101 Marina Village Parkway, Suite 201, Alameda, California 94501.
- Space Size: 135 square feet.
- Lease Terms: One-year lease with a base monthly rent of $947.
- Inclusions: The rent covers office furniture rental, janitorial services, utilities, and internet service.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on strategy, specific risks, contingencies, or unusual items beyond the office relocation.
Investor Verification Checklist
- Verify the operational impact of reducing office space to 135 square feet on the company's research and development capabilities.
- Confirm the total annual cost of the new lease ($11,364) relative to the company's cash position.
- Review subsequent filings to ensure the new location meets regulatory requirements for a biotechnology firm.